Each year serum samples from thousands of antenatal patients are examined to identify the very small proportion of these women who have syphilis. It is the aim of a routine diagnostic laboratory to detect all sera containing treponemal antibody, the clinical significance of which may then be assessed by the physician. Serum from most patients with untreated active syphilis contains non-specific 'reagin' antibodies, which, by using highly sensitive tests, are more easily and cheaply detected by simple serological means than are specific treponemal antibodies. It is the practice of many laboratories to select the sera which contain 'reagin' antibodies by preliminary screening tests with lipoidal antigens, eg, Maltaner cardiolipin and VDRL antigens. These selected sera are then further examined for the presence of treponemal antibodies, commonly by means of a Reiter protein complement-fixation test. Some patients with early, late, latent, or treated syphilis have serum devoid of 'reagin' antibodies but containing treponemal antibodies; these patients cannot be detected serologically by a preliminary screening with lipoidal antigen tests alone.
The present study was undertaken to determine what proportion of sera from antenatal patients contained treponemal antibodies in the absence of reagin antibodies; with this figure and additional serological and clinical information it is possible to decide whether the Reiter protein complementfixation test, if applied to all antenatal sera in addition to lipoidal antigen tests, contributes substantially to the identification of sera from patients with treponemal infection.
MATERIALS AND METHODS
SERA Serological tests were performed on all sera from pregnant women submitted from five centres to the Bristol Public Health Laboratory during the period January 1966 to June 1967. Most blood samples had had a preliminary blood group analysis but none had been selected by preliminary lipoidal antigen tests. Sera were stored at 4°C and inactivated for 30 minutes at 56°C before testing.
ROUTINE SEROLOGICAL TESTS The Reiter protein complement-fixation test (RPCF) and a Wassermann reaction (CLCF), using Maltaner cardiolipin antigen, were used routinely. The method was an adaptation of the modified Whitechapel technique (Association of Clinical Pathologists, Broadsheet 41) using commercial antigens (Burroughs Wellcome & Co.) and WHO perspex haemagglutination plates in a one-hour fixation test at 37°C. Sera were examined at a dilution of 1 in 5 in veronal-buffered saline. The test dose of complement for the diagnostic row in the CLCF was 1V25 MHD and that for the RPCF and control row was 1 00 MHD.
The VDRL slide test (US Public Health Service Manual of Serologic Test for Syphilis, 1964) was done using stabilized antigen (Burroughs Wellcome & Co.) .
Positive control serum Aliquots of a reconstituted freeze-dried stock of positive control serum from a single donation of blood was tested quantitatively on each occasion to check the day-to-day sensitivity of the tests.
REFERENCE LABORATORY TESTS Sera giving reactive results in one or more routine tests on two samples of serum from the same patient were sent to the Venereal Disease Reference Laboratory, the London Hospital, for Treponema pallidum immobilization (TPI), fluorescent treponemal antibody (FTA), and repeat routine tests.
RESULTS
SEROLOGICAL RESULTS Sera from 35,912 pregnant women were examined. One hundred and twentyseven of these gave reactive results in one or more of the routine tests and 48 were found to give reactive TPI or FTA tests (Table I) .
Thirty-five of the 48 TPI or FTA reactive sera also gave reactive lipoidal antigen tests; 27 of these sera were associated with reactive Wassermann tests and eight with reactive VDRL slide tests but non-reactive Wassermann tests. Thirteen of these 48 sera were detected by a reactive RPCF testand would not have been identified by tests for 'reagin' antibody.
The same serum samples when examined at the routine and reference laboratories showed close agreement in the reactions to the routine tests. The maintenance of a high degree of sensitivity of the routine laboratory tests resulted, however, in some loss of specificity of the RPCF reaction; seven of the 48 TPI or FTA reactive sera gave reactive tests in the routine laboratory which were non-reactive to the corresponding tests in the reference laboratory; three of these sera gave reactive reagin tests and four reactive RPCF tests in the routine laboratory only. Forty-five of the 82 patients with reactive RPCF tests also had reactive TPI or FTA results whereas 17 were associated with non-reactive TPI or FTA tests and 20 patients either had an invalid TPI/FTA result or could not be examined further. The majority of sera (32 of 39 sera) with both reactive RPCF and reagin tests were also TPI or FTA positive. However, only approximately one in three sera (13 of 43) which gave a reactive RPCF test in association with non-reactive reagin tests was found to be TPI or FTA positive.
Routine serological tests related to clinical significance The 48 patients who, in addition to one or more reactive routine tests, were also shown to have reactive TPI or FTA serology were classified as having serological evidence of a treponemal infection (Table II) . The remaining 79 patients with reactive routine tests were considered to be showing biological false positive serological reactions related to pregnancy or other non-treponemal conditions.
After clinical assessment, 39 of the 48 patients with serological evidence of treponemal infection were classed as having probable syphilis, 34 in the latent or cured stages, one with neurosyphilis, and four with congenital syphilis; however, yaws could not be excluded with certainty in some of these patients. Nine patients were diagnosed as having yaws or an allied treponemal infection; one of these women was of European origin but had spent several years in a prisoner-of-war camp in the Philippines.
Sixteen of the patients with probable syphilis and In agreement with Wilkinson and Rayner (1966) (Smith, 1967) . Where there is an apparent discrepancy between the clinical and serological findings the fluorescent treponemal antibody absorption test may be useful, since this test is claimed to be more specific and sensitive than the TPI (Stevens, Boylan and Memoli, 1967) .
These sera from women in their first or subsequent pregnancy gave 0 3 % reactive serological results which lies within the range of 005% and 0-42% given by Pritchard, Mechie, McHugh, and Boot (1967) for women examined during their first pregnancy. The proportion of non-specific reactive routine tests was 62 % in the present series but this proportion may be expected to rise during the course of epidemic infections or following a widespread immunization programme such as vaccination. The 0I10% RPCF false positive reactions (37 of 35,785 patients) in this series compares favourably with that of not greater than 0 55 % found by Sequeira (1959) who examined sera from males as well as females.
In the south-west of England the immigrant population is small when compared with some areas of the United Kingdom. In this regional population only half of those patients with serological evidence of treponemal infection inpregnancy were found to require antibiotic treatment. In the present study approximately one in 100 immigrant and one in 2,500 non-immigrant pregnant women were treated for a treponemal infection.
It is evident from these results that routine tests on antenatal sera, if restricted to the detection of 'reagin' antibodies, fail to identify a third of the patients who have serological evidence of treponemal infection. The majority of patients with active syphilis have 'reagin' as well as treponemal antibodies. Since most patients are examined serologically for syphilis only once in each pregnancy, it is important to ensure that as few as possible of those with treponemal infection remain undetected by this serological diagnostic screen. As one cannot differentiate serologically between the different trepanematoses, such as yaws and T. pallidum infections, the significance of reactive serological findings must be gauged by clinical assessment.
The continuing need to maintain adequate serological supervision of pregnant women has been emphasized (Lancet, 1967) . This supervision is necessary in each and every pregnancy both for the welfare of the infected mother and her unborn child and for the elimination of a reservoir of T. pallidum. This paper is presented to support a belief that the diagnosis of syphilis in pregnancy is a current medical problem which justifies periodic reappraisal of routine laboratory methods. The addition of a Reiter protein complement-fixation test to the tests for 'reagin' antibody adds not only specificity but also sensitivity (Sequeira, 1962) . The reliability and limitations of the RPCF test have been summarized by Bekker (1962) . The present study confirms that in antenatal serological diagnosis the application of a routine RPCF test results in a significant increase in the number of reactive sera identified at the cost of only a small amount of time and money.
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